News & events
Q-linea announces FDA submission for expanded claims for ASTar® BC G- panel
Q-linea resolves to carry out a directed issue of shares to a guarantor in connection with the completed preferential rights issue
Q-linea AB (publ) (”Q-linea” or the “Company”) (Nasdaq Stockholm: QLINEA) announces that the Company's board, with the support of...
Read more >
Q-linea announces outcome of rights issue
Q-linea AB (publ) (”Q-linea” or the “Company”) (Nasdaq Stockholm: QLINEA) announces the outcome of the Company’s rights issue of...
Read more >
Q-linea publishes prospectus in connection with the rights issue
Q-linea AB (publ) (”Q-linea” or the “Company”) (Nasdaq Stockholm: QLINEA) publishes a prospectus in connection with the rights issue...
Read more >
BULLETIN FROM Extraordinary GENERAL MEETING IN Q-LINEA AB (PUBL)
The extraordinary general meeting of Q-linea AB (publ) (the “Company”), org.nr. 556729-0217, was held on October 21, 2025 in...
Read more >
Stuart Gander appointed CEO and Anders Ljunggren appointed deputy CEO of Q-linea AB
The board of directors of Q-linea AB (publ) has today appointed Stuart Gander as CEO of the company. Former...
Read more >
Load more